Venlafaxine: a new class of antidepressant
- PMID: 12357859
- DOI: 10.12968/hosp.2002.63.9.1952
Venlafaxine: a new class of antidepressant
Abstract
Venlafaxine represents a new class of antidepressant, the serotonin and noradrenaline re-uptake inhibitor (or SNRI). This article discusses its evolution, pharmacological properties and role in the treatment of depression and related disorders, beginning with an outline of the biology of depression.
Similar articles
-
Pneumonitis related to venlafaxine.Psychosomatics. 2008 Jan-Feb;49(1):84-5. doi: 10.1176/appi.psy.49.1.84. Psychosomatics. 2008. PMID: 18212183 No abstract available.
-
Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.Acta Psychiatr Scand Suppl. 2002;(415):24-30. doi: 10.1034/j.1600-0447.106.s415.5.x. Acta Psychiatr Scand Suppl. 2002. PMID: 12492770
-
[Discontinuation of antidepressant serotonergic antidepressant].Ugeskr Laeger. 2010 Jan 25;172(4):296-8. Ugeskr Laeger. 2010. PMID: 20105399 Danish.
-
The treatment of depression with different formulations of venlafaxine: a comparative analysis.Hum Psychopharmacol. 2004 Jan;19(1):9-16. doi: 10.1002/hup.551. Hum Psychopharmacol. 2004. PMID: 14716706 Review.
-
Rapid onset of action of venlafaxine.Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:21-7. doi: 10.1097/00004850-199503002-00005. Int Clin Psychopharmacol. 1995. PMID: 7622814 Review.
Cited by
-
Duloxetine for childhood depression with pain and dissociative symptoms.Eur Child Adolesc Psychiatry. 2006 Dec;15(8):496-9. doi: 10.1007/s00787-006-0553-4. Epub 2006 May 26. Eur Child Adolesc Psychiatry. 2006. PMID: 16732464
-
Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer.Case Rep Genet. 2017;2017:6236714. doi: 10.1155/2017/6236714. Epub 2017 Oct 16. Case Rep Genet. 2017. PMID: 29123929 Free PMC article.